Review Maps How CRISPR Delivery Could Target Aging's Hallmarks

The paper is a review, not a new experiment. It appears in Ageing Research Reviews (2026), and its authors are Rathore, Gupta, Shah, Chauhan and Gupta. It surveys existing research rather than testing anything in people or animals itself.

CRISPR is a gene-editing tool. It uses a guide molecule made of RNA to steer an enzyme called Cas to a chosen spot in DNA. The enzyme cuts the DNA there. The cell's own repair machinery then fixes the cut, and that repair is how a genetic change is made. The study says the Cas9 enzyme can cut at an exact site, which allows accurate changes inside living cells with a nucleus.

The review looks at several versions of the technology: Cas9, Cas12, base editing, prime editing and CRISPR-based gene regulation. The study says these advances have improved the precision and flexibility of genome editing. It puts the most emphasis on neurodegenerative diseases, including Alzheimer's and Parkinson's.

What would it take to move gene editing toward aging? The authors point to a list of hurdles. These are inefficient delivery to specific tissues, off-target edits (changes in the wrong place in the genome), immune reactions, complex manufacturing and long-term safety concerns. The study describes these as limits on clinical use today.

Delivery gets particular attention. The review evaluates viral methods, including adeno-associated viruses and lentivirus vectors. It also covers non-viral methods: lipid nanoparticles, gold nanoparticles, exosomes, electroporation and microinjection. The study says each has therapeutic potential and translational limits. It does not rank them or say which is closest to use.

On the biology of aging, the authors say current studies show preclinical potential for three hallmarks: genomic instability, telomere attrition and mitochondrial dysfunction. Genomic instability means accumulating DNA damage. Telomeres are the protective caps on chromosomes, and attrition means they wear down. Mitochondria are the cell's energy producers. Preclinical means the evidence comes from lab work, not from human trials.

Other hallmarks are further behind. Work on stem cell exhaustion, epigenetic changes and shifts in the microbiome is at an earlier stage of development.

For you

What this means for personal health is limited for now. The study reports no human trial results and no evidence that editing genes slows aging in people. Gene editing for aging remains a research aim. The review's own framing is that safe, precise and clinically usable treatments are a future goal.

Watch next for progress on tissue-specific delivery and long-term safety data, since the review identifies those as the barriers to clear before any aging-related editing can reach the clinic.

Removing Brain Immune Cells Restored Two Hours of Sleep in Alzheimer's Mice Gut Bacteria and Chemicals Differ in Mild Cognitive Impairment, Small Study Finds Starting Statins Soon After Diabetes Diagnosis Linked to Less Dementia Flavourings, Colourings and Sweeteners Linked to Higher Depression Risk Older Adults on Self-Chosen Vegan Diet Lost Leg Muscle in 12 Weeks Topical Vitamin K2 Cream Improved Wrinkles and Firmness in Small Trial Staying Active Over Years Linked to 44% Lower Frailty Risk East Germans Who Faced Covert State Repression Still Report More Stress Four Cardio Styles Compared: High-Intensity Intervals Beat Moderate Intervals on Fitness AI Predicted Brain Amyloid From Blood Tests, but Faltered on New Patients Boosting Gene ZNF865 With CRISPR Reversed Aging Signs in Degenerated Spinal Disc Cells Review of 26 Cohorts Links Time-Restricted Eating to Better Blood Sugar Years of Fitbit Data Link Steady Daily Rhythms to Slower Biological Aging Review of Nine Meta-Analyses Links Hearing Loss to 43% Higher Dementia Odds UK Biobank Study of 170,000 Women Links HRT to Higher Cardiovascular Risk Small Trial Finds Ultra-Processing Alone Did Not Change Short-Term Satiety Combining Cardio and Strength Training Beats Cardio Alone in Heart Rehab 20-Gram Protein Dose Failed to Boost Muscle Building in Older Men Mediterranean Diet Linked to Slightly Younger DNA-Based Aging Readings in Study Gut Microbes May Shape How Environmental Toxicants Affect the Brain, Review Says Review Says Simply Raising NAD+ or SIRT1 May Not Slow Ageing Review Calls Chronic Stress Before Surgery a Possible Modifiable Heart Risk Review Maps How CRISPR Delivery Could Target Aging's Hallmarks Deep Learning Model Melody Reads DNA Code to Predict Methylation Patterns Mostly-Easy Polarized Training Beat Threshold Workouts on Endurance Markers, Not VO2max Trump Executive Order Creates New NIH Division and Task Force on Women's Health Review of 46 Studies Finds Ultra-Processed Food Heart Research Methodologically Weak Review Finds No Consistent Epigenetic Age Reversal From Antioxidant Supplements Time-Restricted Eating Raises Ketones, Modestly Calms Inflammation, Review Finds Gut-Made Short-Chain Fatty Acids Linked to Brain Protection in Low Blood Flow